Suppr超能文献

苄氟噻嗪对清醒尿崩症大鼠产生抗利尿作用的机制。

Mechanism of antidiuresis caused by bendroflumethiazide in conscious rats with diabetes insipidus.

作者信息

Grønbeck L, Marples D, Nielsen S, Christensen S

机构信息

Department of Pharmacology, University of Copenhagen, Denmark.

出版信息

Br J Pharmacol. 1998 Feb;123(4):737-45. doi: 10.1038/sj.bjp.0701653.

Abstract
  1. The mechanism underlying the antidiuretic effect of thiazide diuretics in diabetes insipidus (DI) is unknown. This study addressed two specific questions: is the reduction in urine flow rate (V) related to a decrease in the delivery of fluid from the pars recta of the proximal tubules ('distal delivery'), and are there any changes in the expression and/or intracellular distribution of vasopressin stimulated water channels (AQP2) in the collecting ducts, during chronic thiazide-induced antidiuresis? 2. Nine Brattleboro rats with vasopressin-deficient DI were treated for 5 days with bendroflumethiazide (BFTZ), 9 mg kg(-1) day(-1) orally, and 9 Brattleboro rats were left untreated. BFTZ-treated DI rats showed a fall in V from approximately 200 to approximately 75 ml day(-1) and an increase in urine osmolality from approximately 130 to approximately 400 mosmol kg(-1). 3. BFTZ-induced antidiuresis was associated with a persistent loss of sodium, but not of potassium. After 5 days of treatment, clearance studies in conscious rats showed a tendency towards decreases in effective renal plasma flow (-7%), GFR (-12%) and lithium clearance (C(Li); used as marker for distal delivery) (-25%), compared with untreated controls, but none of these changes were statistically significant. There was no apparent relationship between C(Li) and V in BFTZ-treated or untreated DI rats. 4. BFTZ treatment did not change the expression of AQP2 in homogenates of cortex, outer or inner medulla from DI rats, or from normal Long Evans rats. Light and electron microscopic immunocytochemistry revealed no changes in intracellular distribution of AQP2 in principal cells from inner medullary collecting ducts of BFTZ-treated DI rats. 5. We concluded, (i) that although the antidiuretic effect of BFTZ in rats with DI is associated with a net loss of Na, the decrease in V shows no association with changes in distal delivery, as estimated by C(Li). (ii) Antidiuretic treatment with BFTZ does not alter the expression of subcellular distribution of AQP2 water channels in the collecting ducts. The mechanism underlying the chronic antidiuresis caused by thiazide diuretics in DI remains elusive.
摘要
  1. 噻嗪类利尿剂对尿崩症(DI)产生抗利尿作用的机制尚不清楚。本研究探讨了两个具体问题:尿流率(V)的降低是否与近端小管直部液体输送量(“远端输送”)的减少有关,以及在慢性噻嗪类药物诱导的抗利尿过程中,集合管中血管加压素刺激的水通道(AQP2)的表达和/或细胞内分布是否有任何变化?2. 9只患有血管加压素缺乏性尿崩症的布拉德福德大鼠口服苄氟噻嗪(BFTZ),剂量为9 mg·kg⁻¹·d⁻¹,持续治疗5天,另外9只布拉德福德大鼠未接受治疗。接受BFTZ治疗的尿崩症大鼠的V从约200 ml·d⁻¹降至约75 ml·d⁻¹,尿渗透压从约130 mosmol·kg⁻¹升至约400 mosmol·kg⁻¹。3. BFTZ诱导的抗利尿作用与持续的钠丢失有关,但与钾丢失无关。治疗5天后,清醒大鼠的清除率研究显示,与未治疗的对照组相比,有效肾血浆流量(-7%)、肾小球滤过率(-12%)和锂清除率(C(Li);用作远端输送的标志物)(-25%)有下降趋势,但这些变化均无统计学意义。在接受BFTZ治疗或未治疗的尿崩症大鼠中,C(Li)与V之间没有明显关系。4. BFTZ治疗并未改变尿崩症大鼠或正常长 Evans 大鼠皮质、外髓或内髓匀浆中 AQP2 的表达。光镜和电镜免疫细胞化学显示,接受BFTZ治疗的尿崩症大鼠内髓集合管主细胞中 AQP2 的细胞内分布没有变化。5. 我们得出结论:(i)尽管BFTZ对尿崩症大鼠具有抗利尿作用,且与净钠丢失有关,但V的降低与C(Li)估计的远端输送变化无关。(ii)BFTZ的抗利尿治疗不会改变集合管中 AQP2 水通道的亚细胞分布表达。噻嗪类利尿剂在尿崩症中引起慢性抗利尿作用的机制仍然难以捉摸。

相似文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验